Price $9.41 |
Market Cap
356.1M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.0
|
P/S
1.22
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-23K
|
FCF
-0.6
|
|
Op. Margin
-10.10%
|
Net Margin
-9.70%
|
ROE
-7.80%
|
ROI
-5.60%
|
|
ROA
-5.90%
|
EPS Growth
16.10%
|
Current Ratio
1.9
|
Debt/Equity
5.90%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Biostem Technologies Inc (BSEM) | $2.00 | - | - | 42.5M | Strong Buy |
| Cumberland Pharmaceuticals, In (CPIX) | $1.59 | - | - | 28M | Strong Buy |
| POINT Biopharma Global Inc (PNT) | $9.15 | - | - | 733.4M | Strong Buy |
| Orthofix Medical Inc (OFIX) | $18.67 | - | - | 587.7M | Strong Buy |
| Taysha Gene Therapies Inc (TSHA) | $0.68 | - | - | 46M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
